Please resolve the following issues before proceeding
Click on an issue to go directly to the related section of the form.
errors found:
warnings found:

Getting Started

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required
Do you need to complete this form?
This form is for prescribers who need to apply for a warrant to treat patients with one or more of the following restricted Schedule 4 medicines:Ovulatory stimulantsProstaglandinsRetinoidsImmunomodulatory drugs (IMiDs) (thalidomide or its analogues)
NOTE: Once you have completed and submitted this form, you will receive a confirmation email that your completed form has been received by the department, as well as a PDF of your completed form for your records.

Prescriber Details

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required

Your details

Qualifications (select all applicable) *

Practice details

Warrant details

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required
I am applying for a warrant to obtain, use, supply or prescribe: *

Ovulatory stimulant details

I am applying for a warrant to treat patients with clomiphene citrate for: (select relevant option)

Prostaglandin details

a) I am applying for a warrant to treat patients with prostaglandin E2 (dinoprostone) for induction of labour and prostaglandin F (dinoprost trometamol) for procedures relating to termination of pregnancy or post-partum haemorrhage and:

OR
b) I am applying for a warrant to treat patients with prostaglandin E2 (dinoprostone) for induction of labour and:

Retinoid details

I am applying for a warrant to treat patients with: (select relevant option)

IMiDs details

I am applying for a warrant to treat patients with: (select relevant option/s) *

Supporting documentation

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required

In support of your application, please attach the following:

Evidence of specialist qualifications

Attach documentary evidence of your relevant specialist qualifications here:
File:

Supporting documentation

Attach documentary evidence of your accreditation to practice obstetrics at a hospital here:
File:

Supporting documentation

Attach documentary evidence of your appointment as an obstetrics and gynaecology registrar in a training program in a public hospital or evidence that you are a Member of the College (MRANZCOG) here:
File:

Patient-based warrant (ovulatory stimulant)

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required

Patient-based warrant details

If "clomiphene citrate for other purposes" has been selected, the following details must be completed:
Patient Details

Evidence of specialist qualifications

1. Attach documented evidence confirming your specialist qualifications and that you are a specialist in a field relevant to the patient's medical condition:
File:

Evidence demonstrating efficacy for the therapeutic use of clomiphene citrate for the patient’s condition

2. Attach documented evidence or medical literature which demonstrates efficacy for the therapeutic use of clomiphene citrate for the patient's medical condition:
File:

Patient-based warrant (retinoid)

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required

Patient-based warrant details

If "a retinoid for other purposes" has been selected, the following details must be completed:
Patient Details
Retinoid: (select relevant drug) *

Evidence of specialist qualifications

1. Attach documented evidence confirming your specialist qualifications and that you are a specialist in a field relevant to the patient's medical condition:
File:

Evidence demonstrating efficacy for the therapeutic use of the retinoid for the patient’s condition

2. Attach documented evidence or medical literature which demonstrates efficacy for the therapeutic use of the retinoid for the patient's medical condition:
File:

Patient-based warrant (IMiDs)

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required

Patient-based warrant details

If "thalidomide, lenalidomide or pomalidomide for other purposes" has been selected, the following details must be completed:
Patient Details
Immunomodulatory drug (IMiD): (select relevant drug) *

Evidence of specialist qualifications

1. Attach documented evidence confirming your specialist qualifications and that you are a specialist in a field relevant to the patient's medical condition:
File:

Evidence demonstrating efficacy for the therapeutic use of the IMiD for the patient’s condition

2. Attach documented evidence or medical literature which demonstrates efficacy for the therapeutic use of the IMiD for the patient's medical condition:
File:

Support from a relevant ethics committee

3. Attach documented evidence of support for your application from a relevant ethics committee, such as from a hospital or a professional College in your field of specialty:
File:

Declaration

Application for a warrant to obtain, use, supply or prescribe restricted Schedule 4 medicines
Fields marked with * are required

Declaration

This application forms part of a legal document and penalties exist for providing false or misleading information.

I, , declare that:
I will treat only the following patients with a retinoid:
a. males; or
b. females who are not pregnant or for whom the possibility of pregnancy occurring can be ruled out or that adequate safeguards are in place to ensure that pregnancy does not occur during the course of treatment; and
i. for one month after cessation of treatment with isotretinoin or tretinoin; and
ii. for two years after cessation of treatment with acitretin or etretinate.
I will undertake to use prostaglandins for obstetric purposes only under conditions where facilities for cardiotocographic monitoring and emergency Caesarean section are available.
For patients treated with immunomodulatory drugs (IMiDs), I will take all reasonable steps to ensure that:
a. for females pregnancy can be ruled out, or that adequate safeguards are in place to ensure that pregnancy can be ruled out during treatment with the drug and for at least one month after stopping the drug;
b. sexually active males who have not had a vasectomy are informed that it is recommended that:
i. they abstain from sexual intercourse, or use a condom during intercourse, while receiving the drug, and continuing thereafter until one month after the last dose, and
ii. sperm should not be donated during this period.
I confirm the information I provided in this application is true and complete to the best of my knowledge.

Privacy Statement

It is a requirement of the Drugs, Poisons and Controlled Substances Act 1981 (the Act) that the information set out in this form is provided to the Department of Health & Human Services to meet statutory notification requirements, and for the issuing of permits as required under the Act. The collection, use and disclosure of the information provided will be in accordance with the law, including the provisions of the Health Records Act 2001. The information collected may be disclosed to health practitioners practising in the following health professions: medical, nursing and midwifery and pharmacy, when necessary to facilitate coordination of the patient's drug treatment and safe prescribing of drugs. For example, it may be necessary to disclose this information when another health practitioner applies for a permit or is considering prescribing a drug of dependence. The application may not be processed if all information requested on the form is not completed.
Department of Health & Human Services